UA Frame EN

Welcome to licensed pharmacies in Poland:

Non-prescription medicines delivery across Europe.

Frequently ordered: potency boosters (sildenafil OTC), quit smoking aids.

Zdrowa (Anonymous, 83.5.208.) Warszawa 3 days ago

What are the risks of abruptly discontinuing the Evertas patch?

What are the risks of suddenly discontinuing the Evertas patch? I'm afraid that it raises my blood pressure, which is difficult to reduce.

1 answer, 1 subscriber

* required field

You can drag the photo file here.

* required field

Notify of a new answer.
Other messages will not be sent.

Suggested Products

Space for your product

Your product would fit here?

Set up a sponsored products campaign yourself:

Check

Anna Lewandowska Pharmacist, Editor

2 days ago

The use of Evertas (rivastigmine) patches may cause an increase in blood pressure as a side effect in some people, although this is not very common.

Rivastigmine affects the nervous and cardiovascular systems, which can lead to symptoms such as fast or uneven heartbeat and high blood pressure. If hypertension occurs while taking the drug, consult a doctor who can adjust the dose or suggest other therapeutic solutions.

Do not stop treatment on your own without consultation. Abruptly stopping the Evertas patch can lead to worsening of Alzheimer's disease symptoms because this drug increases the levels of acetylcholine in the brain, which relieves the symptoms of dementia.

If you need more personalized advice, you can use teleconsultations here:

https://www.gdziepolek.pl/telekonsultacja/

The availability of Evertas in pharmacies in Polish can be checked at the following address:

https://www.gdziepolek.pl/produkty/28606/evertas-system-transdermalny/apteki

Appreciate the answerer and highlight the question on the home page
User questions and answers that provide feedback about products are not verified for the purchase or use of the product. Companies often order anonymous comments to form positive opinions about their products, or negative ones about competitors. Therefore, be guided by the information in the pharmacists' responses in the first place.

Specialists